<?xml version="1.0" encoding="UTF-8"?>
<ref id="sct312331-bib-0016">
 <label>16</label>
 <mixed-citation publication-type="journal" id="sct312331-cit-0016">
  <string-name>
   <surname>Alvaro‐Gracia</surname>
   <given-names>JM</given-names>
  </string-name>, 
  <string-name>
   <surname>Jover</surname>
   <given-names>JA</given-names>
  </string-name>, 
  <string-name>
   <surname>Garcia‐Vicuna</surname>
   <given-names>R</given-names>
  </string-name> et al. 
  <article-title>Intravenous administration of expanded allogeneic adipose‐derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, single‐blind, placebo‐controlled phase Ib/IIa clinical trial</article-title>. 
  <source xml:lang="en">Ann Rheum Dis</source>
  <year>2017</year>;
  <volume>76</volume>:
  <fpage>196</fpage>‐
  <lpage>202</lpage>.
  <pub-id pub-id-type="pmid">27269294</pub-id>
 </mixed-citation>
</ref>
